HeartSciences Inc.

HSCS

We are a healthcare information technology company focused on advancing electrocardiography ( ECG or EKG ) through the integration of artificial intelligence ( AI ). Our first commercial product is MyoVista Insights , a cloud-native, vendor- and device-agnostic ECG management platform designed to modernize ECG workflows and enable scalable deployment of AI-ECG capabilities acro…

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$15M

EPS-$3.15

P/E-0.98

Div. Yield–

Net Margin-227024.23%

P/Book–

HeartSciences Inc. intrinsic value

52-Week Range

$1.67$5.20

Profitability & Returns

TTM as of 2026-07 · YoY vs prior year · ROIC = NOPAT / invested capital

Revenue (TTM)

$5K

Net Income (TTM)

-$10M

Net Margin

-227024.23%

P/E

–

Balance Sheet

Traditional FCF and net-debt metrics are not meaningful for financial institutions · Balance sheet from latest filing

Total Assets

$4M

Equity

-$2M

Total Debt

$4M

Cash & Equiv.

$30K

3Y CAGR: -5.7%

Continue Research

Quality Scorecard

Is this a high-quality business?

Dividends

Payout safety and growth

Intrinsic Value

What is it worth?

Financials

Full income, cash flow, balance sheet

Peers

Finance Services · Pick stocks to compare with HSCS

CompareIntrinsic value

COSGCosmos Group Holdings Inc.

$0.03-58.40%15

NBNDNetbrands Corp

$0.00-20.00%0

GPGIGPGI Inc

$12.78+9.42%24

TRXATrex Acquisition Corp.

$0.52+0.00%0

BTOGBit Origin Ltd

$2.21+0.00%35

TGNTTotaligent, Inc.

$0.01+0.00%0

HeartSciences (HSCS) in three numbers

Quality score: 0/100; Best check: revenue growth, -3.2%.; Quality
Dividend: None; No dividend in the SEC filings we hold.; Dividends
P/E: -0.98; Negative: a loss over the last twelve months. Price to free cash flow -2.19.; Financials

Questions about HeartSciences

Is HeartSciences a high-quality business?

HeartSciences scores 0 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 4 checks computed from SEC filings. Its best check is revenue growth at -3.2%. The Quality tab shows every check against its target.

Does HeartSciences (HSCS) pay a dividend?

No. HeartSciences (HSCS) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 11 Sept 2026 (period ending 31 Jul 2026), SEC. Price: last close 4 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in HSCS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing HSCS

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.